For the year ending 2025-12-31, AIDX made $2,045,133 in revenue. -$3,738,821 in net income. Net profit margin of -182.82%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 2,045,133 | |||
| Cost of revenues | 1,440,592 | |||
| Gross profit | 604,541 | |||
| Sales, general and administrative | 3,342,843 | |||
| Research and development | 592,569 | |||
| Total operating expenses | 3,935,412 | |||
| Operating loss | -3,330,871 | |||
| Interest expense | 156,207 | |||
| Interest income | 21,399 | |||
| Change in fair value of derivative liabilities | 7,737 | |||
| Loss on issuance of convertible note | -280,764 | |||
| Other (expense) income, net | -115 | |||
| Total other (expense) income | -407,950 | |||
| Net loss | -3,738,821 | |||
| Basic EPS | -0.76 | |||
| Diluted EPS | -0.76 | |||
| Basic Average Shares | 4,930,287 | |||
| Diluted Average Shares | 4,930,287 | |||
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)